1-6 of 6
Ronald McCord
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Longitudinal Analysis of Circulating Tumor DNA (ctDNA) in Diffuse Large B-Cell Lymphoma (DLBCL) Using KAPA HyperCap Design Share Non-Hodgkin Lymphoma (KAPA HyperCap DS NHL) Next-Generation Sequencing (NGS) Panel

Vladislava Melnikova, Clara Bermejo, Richard Chien, Parul Agarwal, Alexandra Markus, Bowdoin Su, Renee Stokowski, Ronald McCord, Alex F. Herrera, Laurie H. Sehn
Journal: Blood
Blood (2023) 142 (Supplement 1): 6082.
https://doi.org/10.1182/blood-2023-182093
Published: 2023
Journal Articles

Glofitamab Plus R-CHOP Induces High Response Rates with a Manageable Safety Profile in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A 12-Month Analysis from a Phase Ib Study

Max S. Topp, Monica Tani, Michael Dickinson, Nilanjan Ghosh, Armando Santoro, Antonio Pinto, Francesc Bosch, Christopher P. Fox, Armando Lopez-Guillermo, Thomas Gastinne, Andreas Viardot, William Townsend, Naseer Qayum, Martin Barrett, Derrick Kaufman, Chun Wu, Ronald McCord, Pauline Baumlin, Patrick Kimes, Franck Morschhauser
Journal: Blood
Blood (2023) 142 (Supplement 1): 3085.
https://doi.org/10.1182/blood-2023-174081
Published: 2023
Journal Articles

Risk Profiling of Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) By Measuring Circulating Tumor DNA (ctDNA): Results from the POLARIX Study

Alex F. Herrera, Ronald McCord, Patrick Kimes, Fabrice Jardin, Georg Lenz, Marek Trneny, Christopher R. Flowers, Laurie H. Sehn, Gilles Salles, Jeff P. Sharman, Hervé Tilly, Jonathan W. Friedberg, Charles Herbaux, Matthew J. Matasar, Corinne Haioun, Samuel Tracy, Jamie Hirata, Calvin Lee, Yanwen Jiang, Franck Morschhauser
Journal: Blood
Blood (2022) 140 (Supplement 1): 1297–1300.
https://doi.org/10.1182/blood-2022-157559
Published: 2022
Journal Articles

Mosunetuzumab, a Novel CD20/CD3 Bispecific Antibody, in Combination with CHOP Confers High Response Rates in Patients with Diffuse Large B-Cell Lymphoma

Tycel J. Phillips, MD, Adam J Olszewski, MD, Javier Munoz, MD, Tae Min Kim, MD PhD, Dok Hyun Yoon, Richard Greil, MD, Jason Westin, MD, Ulrich Jaeger, Miguel Canales, Cindy Chen, Betsy Althaus, Carol O'Hear, Raluca Negricea, Yuying Xie, Ronald McCord, Enkhtsetseg Purev, Anusha Vallurupalli
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-136295
Published: 2020
Journal Articles

High Expression of Programmed Death-Ligand 1 (PD-L1) Correlates with Macrophage Gene Expression and Is Associated with Prolonged Progression-Free Survival (PFS) in Patients (pts) with First-Line (1L) Diffuse Large B-Cell Lymphoma (DLBCL)

Ronald McCord, Christopher Bolen, Hartmut Koeppen, Edward E. Kadel, III, Günter Fingerle-Rowson, Mikkel Z. Oestergaard, Jeffrey M. Venstrom
Journal: Blood
Blood (2017) 130 (Supplement 1): 195.
https://doi.org/10.1182/blood.V130.Suppl_1.195.195
Published: 2017
Journal Articles

Mutation Load and a Functional T Effector Signature May Distinguish Immunologically Distinct and Clinically Relevant Lymphoma Subsets

Chris Bolen, PhD, Ronald McCord, PhD, Garrett Frampton, PhD, Richard Bourgon, PhD, Elizabeth A. Punnoose, PhD, Edith Szafer-Glusman, PhD, Pierre Sujobert, MD PhD, Luc Xerri, MD PhD, Sarah Huet, PharmD, PhD, Gilles Salles, MD PhD, Jeffrey M Venstrom
Journal: Blood
Blood (2016) 128 (22): 913.
https://doi.org/10.1182/blood.V128.22.913.913
Published: 2016